AstraZeneca's Tozorakimab Shows Positive Results in Two Late-Stage COPD Trials
Full data from late-stage studies reinforce hopes the drug could become a major treatment for chronic obstructive pulmonary disease, according to CNBC.
AstraZeneca's experimental drug tozorakimab has produced positive results in two late-stage clinical trials for chronic obstructive pulmonary disease (COPD), according to a report by CNBC.
The full data from the trials reinforces expectations that the drug could represent a breakthrough treatment for COPD, the report said.
CNBC reported that the results support AstraZeneca's forecast that tozorakimab could reach peak annual sales of more than $5 billion, positioning it as a potential blockbuster medicine for the company.
COPD is a progressive lung disease that makes breathing difficult and affects millions of people worldwide. Treatments that can significantly improve outcomes for patients are considered commercially significant for pharmaceutical companies given the scale of the condition.
Further details on the specific trial design, patient outcomes, and timeline for regulatory submission were not immediately available in the source report.
Sources
- AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes — CNBC — Top News
EGazette summarizes reporting from multiple sources; follow the links for the originals.
Related articles
Thousands of Eligible Families Missing Out on NHS Food Support, Figures Show
New data cited by the BBC indicates that as few as 64% of families entitled to NHS money for milk, fruit and vegetables are actually claiming it.
Three men charged in domestic violence murders as three women killed in NSW within 12 hours
A woman in her 90s in Bondi Beach, a 23-year-old in Wagga Wagga, and a woman in her 70s in Mole River died in separate incidents on Saturday.
Australia's life expectancy forecast to reach 89 for women, 86 for men by 2066
Treasury's intergenerational report projects Australians will live significantly longer over the next four decades.
DR Congo rolls out Ebola vaccine for health workers as death toll rises
The country has begun vaccinating 50,000 frontline health workers against a different Ebola strain while 20,000 are enrolled in a clinical trial.
DR Congo Launches Ebola Vaccine Trials for Frontline Health Workers
Health authorities begin rolling out vaccination trials targeting workers at the centre of the country's Ebola response, according to Al Jazeera.
Thousands of pregnant women in England disclose domestic abuse to midwives, analysis finds
About 20,000 disclosures are estimated to be made to maternity services annually, with experts warning the true figure is likely higher
Comments
Loading comments…